basiliximab (simulect) Report issue

Biologics mAb Orphan Drug FDA Approved FDA Priority Review FDA

Active Ingredient History

NOW
  • Now
Basiliximab is a chimeric mouse-human monoclonal antibody to the α chain (CD25) of the IL-2 receptor of T cells. It is used to prevent rejection in organ transplantation, especially in kidney transplants.   Wikipedia

More Chemistry
  • Mechanism of Action:
  • Multi-specific: No
  • Black Box: Yes
  • Availability: Prescription Only
  • Delivery Methods: Parenteral
  • Pro Drug: No

Drug Pricing (per unit)

United States

$2028.8800 - $3869.5000
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

basiliximab | baxiliximab | chi 621 | chi-621 | chimeric mouse-human anticd25 | chrft5 | sdz chi 621 | sdz-chi-621 | simulect

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue